BioSpace News Archive

Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad

Opinion

Biotech can’t continue to innovate under strain of Big Pharma market pressures

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes are needed to sustain the sector’s strategic innovation.

May 19, 2026

·

5 min read

·

Jeremy Levin

Opportunity of winning. man sees a illuminated trophy door. vector

Cancer

Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer

Merck and Kelun-Biotech’s antibody-drug conjugate significantly improved progression-free and overall survival in a pivotal endometrial cancer study, though the companies have yet to specify when they plan to file for approval.

May 19, 2026

·

2 min read

·

Tristan Manalac

COVID-19

FDA’s own report shows no child deaths definitively caused by COVID vaccination

Despite having no definitive data, Sen. Ron Johnson (R-WI) in a letter to health secretary Robert F. Kennedy, Jr. suggested there was a conscious effort by the Biden administration’s FDA to cover up the safety risks of COVID-19 vaccines.

May 19, 2026

·

3 min read

·

Tristan Manalac

Balloon and missed bow spears arround . Target audience and marketing concept . This is a 3d render illustration .

Rare diseases

BioMarin suffers another blow to rare disease portfolio in Phase 3 flop

BioMarin’s investigational therapy failed to elicit clinical improvements in patients with ENPP1 deficiency, while also missing key secondary endpoints of rickets severity and growth.

May 19, 2026

·

2 min read

·

Tristan Manalac

Illustration showing people forming an arrow versus large arrow

Job Trends

Takeda cuts send layoffs soaring in May, rising year over year

Far fewer companies are letting employees go so far in 2026 compared to 2025, but the number of people affected is trending up, especially this month, according to BioSpace tallies.

May 19, 2026

·

4 min read

·

Angela Gabriel

sprint start in track and field in blurred motion

Rare diseases

Relay doubles the bar, outpacing Novartis with a 60% response in rare disease

Analysts are extremely encouraged by Phase 2 trial results for Relay Therapeutics’ PI3KA inhibitor in treating vascular malformations (VM), prompting the biotech to eye a potential path to accelerated approval.

May 19, 2026

·

2 min read

·

Gabrielle Masson

Press Releases

Autoinjectors Are Redefining Drug Delivery — And the Market Is Exploding

May 19, 2026

·

1 min read

Press Releases

Radyus Research & Development Expands Brand and Leadership Team to Scale PMO-Led Drug Development Model